24,25-Epoxycholesterol, LXR agonist, endogenous cholesterol metabolite (TBI1330)

Description

Product Details

Formal Name: (3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-4-[(2S)-3,3-dimethyloxiran-2-yl]butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

Molecular Formula: C₂₇H₄₄O₂

Formula Weight: 400.65

CAS Number: 77058-74-3

Purity: 98%

Formulation: Powder

Solubility: Soluble in DMSO (up to 30 mg/ml)

Storage: -20°C

Stability: ≥ 2 years.

 

Applications

• LXR agonist, endogenous cholesterol metabolite

 

Related Products

1. TBI1170 Mitomycin C
2. TBI1345 E64, Cysteine protease inhibitor
3. TBI1148 Gefitinib, EGFR Kinase inhibitor
4. TBI2614 ZVAD-FMK, Pan-caspase inhibitor
5. TBI2069 Cytochalasin B

Additional information

SIZE (mg)	1 MG, 5 MG

TBI1330-24,25-Epoxycholesterol